232 related articles for article (PubMed ID: 20978355)
1. Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.
Berres ML; Koenen RR; Rueland A; Zaldivar MM; Heinrichs D; Sahin H; Schmitz P; Streetz KL; Berg T; Gassler N; Weiskirchen R; Proudfoot A; Weber C; Trautwein C; Wasmuth HE
J Clin Invest; 2010 Nov; 120(11):4129-40. PubMed ID: 20978355
[TBL] [Abstract][Full Text] [Related]
2. RANTES antagonism: a promising approach to treat chronic liver diseases.
Affò S; Bataller R
J Hepatol; 2011 Oct; 55(4):936-8. PubMed ID: 21708198
[TBL] [Abstract][Full Text] [Related]
3. Interference with oligomerization and glycosaminoglycan binding of the chemokine CCL5 improves experimental liver injury.
Nellen A; Heinrichs D; Berres ML; Sahin H; Schmitz P; Proudfoot AE; Trautwein C; Wasmuth HE
PLoS One; 2012; 7(5):e36614. PubMed ID: 22574195
[TBL] [Abstract][Full Text] [Related]
4. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
Li BH; He FP; Yang X; Chen YW; Fan JG
Transl Res; 2017 Feb; 180():103-117.e4. PubMed ID: 27639593
[TBL] [Abstract][Full Text] [Related]
5. Functional role of CCL5/RANTES for HCC progression during chronic liver disease.
Mohs A; Kuttkat N; Reißing J; Zimmermann HW; Sonntag R; Proudfoot A; Youssef SA; de Bruin A; Cubero FJ; Trautwein C
J Hepatol; 2017 Apr; 66(4):743-753. PubMed ID: 28011329
[TBL] [Abstract][Full Text] [Related]
6. Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity.
Chen L; Gu J; Qian Y; Li M; Qian Y; Xu M; Li J; Wen Y; Xia L; Li J; Xia Q; Kong X; Wu H
Cell Mol Gastroenterol Hepatol; 2019; 7(3):623-639. PubMed ID: 30630119
[TBL] [Abstract][Full Text] [Related]
7. Mediator MED23 regulates inflammatory responses and liver fibrosis.
Wang Z; Cao D; Li C; Min L; Wang G
PLoS Biol; 2019 Dec; 17(12):e3000563. PubMed ID: 31805036
[TBL] [Abstract][Full Text] [Related]
8. C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice.
Chu PS; Nakamoto N; Ebinuma H; Usui S; Saeki K; Matsumoto A; Mikami Y; Sugiyama K; Tomita K; Kanai T; Saito H; Hibi T
Hepatology; 2013 Jul; 58(1):337-50. PubMed ID: 23460364
[TBL] [Abstract][Full Text] [Related]
9. Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
Stock MK; Hammerich L; do O NT; Berres ML; Alsamman M; Heinrichs D; Nellen A; Trautwein C; Tacke F; Wasmuth HE; Sahin H
Int J Clin Exp Pathol; 2013; 6(4):678-85. PubMed ID: 23573314
[TBL] [Abstract][Full Text] [Related]
10. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.
Li X; Yao QY; Liu HC; Jin QW; Xu BL; Zhang SC; Tu CT
J Cell Mol Med; 2017 Oct; 21(10):2370-2385. PubMed ID: 28378526
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis.
Yang JH; Kim KM; Cho SS; Shin SM; Ka SO; Na CS; Park BH; Jegal KH; Kim JK; Ku SK; Lee HJ; Park SG; Cho IJ; Ki SH
Antioxid Redox Signal; 2019 Jul; 31(3):243-259. PubMed ID: 30909713
[No Abstract] [Full Text] [Related]
12. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
[TBL] [Abstract][Full Text] [Related]
13. PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.
She S; Wu X; Zheng D; Pei X; Ma J; Sun Y; Zhou J; Nong L; Guo C; Lv P; Song Q; Zheng C; Liang W; Huang S; Li Q; Liu Z; Song Z; Li Y; Zhang Y; Kong W; You H; Xi J; Wang Y
J Hepatol; 2020 Mar; 72(3):506-518. PubMed ID: 31813573
[TBL] [Abstract][Full Text] [Related]
14. Matricellular protein periostin contributes to hepatic inflammation and fibrosis.
Huang Y; Liu W; Xiao H; Maitikabili A; Lin Q; Wu T; Huang Z; Liu F; Luo Q; Ouyang G
Am J Pathol; 2015 Mar; 185(3):786-97. PubMed ID: 25541330
[TBL] [Abstract][Full Text] [Related]
15. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
16. C-C Chemokine Ligand-5 is critical for facilitating macrophage infiltration in the early phase of liver ischemia/reperfusion injury.
Lee CM; Peng HH; Yang P; Liou JT; Liao CC; Day YJ
Sci Rep; 2017 Jun; 7(1):3698. PubMed ID: 28623253
[TBL] [Abstract][Full Text] [Related]
17. Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis.
Kim BM; Abdelfattah AM; Vasan R; Fuchs BC; Choi MY
Sci Rep; 2018 May; 8(1):7499. PubMed ID: 29760499
[TBL] [Abstract][Full Text] [Related]
18. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
19. Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis.
Chatani N; Kamada Y; Kizu T; Ogura S; Furuta K; Egawa M; Hamano M; Ezaki H; Kiso S; Shimono A; Ouchi N; Yoshida Y; Takehara T
Liver Int; 2015 Aug; 35(8):2017-26. PubMed ID: 25488180
[TBL] [Abstract][Full Text] [Related]
20. The chemokine CCL3 promotes experimental liver fibrosis in mice.
Heinrichs D; Berres ML; Nellen A; Fischer P; Scholten D; Trautwein C; Wasmuth HE; Sahin H
PLoS One; 2013; 8(6):e66106. PubMed ID: 23799074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
